The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK.
J Pathol. 2009 Nov;219(3):306-16. doi: 10.1002/path.2599.
Heterozygous germline mutations in the LKB1 (STK11) gene cause Peutz-Jeghers syndrome (PJS), an autosomal dominant disorder characterized by hamartomatous polyposis of the gastrointestinal tract and an increased risk of colorectal, breast, and other cancers. To model the role of LKB1 mutation in mammary tumourigenesis, we have used a conditional gene targeting strategy to generate a mouse in which exons encoding the kinase domain of Lkb1 were deleted specifically in the mammary gland. Mammary gland tumours developed in these mice with a latency of 46-85 weeks and occurred in the thoracic or inguinal glands. These tumours were grade 2 invasive ductal carcinomas or solid papillary carcinomas with histological features similar to those described in breast cancers arising in patients with PJS. This mouse model of Lkb1 deficiency provides a potentially useful tool to investigate the role of Lkb1 in tumourigenesis and to guide the development of therapeutic approaches.
种系 LKB1(STK11)基因突变导致 Peutz-Jeghers 综合征(PJS),这是一种常染色体显性疾病,其特征为胃肠道错构瘤性息肉和结直肠癌、乳腺癌和其他癌症风险增加。为了模拟 LKB1 突变在乳腺肿瘤发生中的作用,我们使用条件基因靶向策略在乳腺中特异性缺失编码激酶结构域的 Lkb1 的外显子来生成小鼠。这些小鼠的乳腺肿瘤潜伏期为 46-85 周,发生在胸或腹股沟腺。这些肿瘤为 2 级浸润性导管癌或实性乳头状癌,具有与 PJS 患者发生的乳腺癌相似的组织学特征。这种 Lkb1 缺失的小鼠模型为研究 Lkb1 在肿瘤发生中的作用以及指导治疗方法的发展提供了一个潜在的有用工具。